myCordBank.com: A leading private facility for cord blood and tissue banking, offering unique stem cell storage solutions.
Founded by Dr. Eliott and Dr. Schmid, myCordBank.com is a private, state-of-the-art facility specializing in cord blood and tissue banking. Its core mission is to provide families with advanced stem cell storage solutions that exceed AABB standards. The company offers the industry-leading Multi-use Stem Safe Storage System™, which allows for individual thawing of cells, thereby expanding future treatment options for families. MyCordBank.com focuses on providing unique and reliable processing methodologies that set it apart in the healthcare market.
Notable figures affiliated with myCordBank.com include its founders, Dr. Eliott and Dr. Schmid, who are instrumental in the development and implementation of its innovative storage systems. The company has achieved significant milestones by being the only laboratory to offer this specialized processing methodology. Its impact is reflected in the enhanced treatment possibilities it provides to families, positioning myCordBank.com as a leader in the cord blood and tissue banking industry.

MiracleCord
miraclecord.com

Anja Health
anjahealth.com
Stem Cell Reserve

Stemcyte
stemcyte.com

Next Healthcare

StemSave
stemsave.com
AdiCyte

Vcanbio Cell & Gene Engineering

American CryoStem

Celltex Therapeutics
celltexbank.com

Cell Vault
cellvault.com

Ossium Health
ossiumhealth.com

Personalized Stem Cells

ImmuneBridge
immunebridge.com
Tissue Genesis
tissuegenesis.com

Acorn Biolabs
acorn.me

Forever Labs
foreverlabs.com

Pinnacle Transplant Technologies

Change Agents
Fibulas
Companies similar to MyCordBank.com include MiracleCord, Anja Health, Stem Cell Reserve and Stemcyte.
MyCordBank.com was founded in 1994.
MyCordBank.com's headquarters is located in Sandy, UT, US.
MyCordBank.com's most recent funding round was for $2M (USD) in December 2013.
As of Dec 8, 2013, MyCordBank.com has disclosed funding of $2M (USD).
MyCordBank.com has 8 employees as of Feb 4, 2024.